Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Mid & small caps steal the show
Thu, 7 Apr Closing

Although the Indian stock markets did go into the positive during the closing stages, they could not hold on to the gains for long and eventually ended the day marginally in the negative. Thus, while BSE-Sensex closed with a decline in the region of 20 points, NSE-Nifty lost a meager 6 points. BSE Midcap and BSE Small cap indices hogged the limelight yet again, going up by 1% each. On the Sensex, three stocks fell for every two that ended in the positive.

While most Asian stock markets closed in the positive today, Europe is trading largely in the negative currently. The rupee was seen trading at Rs 44.2 to the dollar at the time of writing.

With the investors lapping up most of the cheap large cap stocks over the past couple of months, the attention seems to have now shifted to mid and small caps. It should be noted that BSE Mid and small cap indices had underperformed its large cap counterpart in the recent rally and hence, the buying trend in these counters is an effort towards making up for lost time and opportunity in the so called smaller market cap indices.

Food stocks closed mixed today with top gainers being Lakshmi Energy and VST Industries. GSK Consumer, the health drink giant also closed in the positive albeit marginally. As per reports, the company is looking to acquire brands so that the growth potential in India could be tapped even further. At the same time though, it is also aware of the steep valuations that are doing the rounds currently. Besides making health drinks brands like Horlicks and Boost, the company is also a distributor of OTC (Over the counter) products like Crocin, Eno and Iodex. Its associate company in India, GSK Asia Private recently launched a toothpaste brand called Sensodyne. Shareholders of the company would have been enthused had the launch been by the listed entity.

The Indian pharma packalso closed mixed today. Leading gainers were Zandu Realty, J B Chemicals and Biocon. Glenmark Pharma was another counter that closed in the positive. This was perhaps on the back of news that the company has entered into an exclusive arrangement with Immanence-IDC, a leading Canadian company for distribution of their high-end anti-ageing cosmeceutical range of products. The agreement will cover eight countries for Glenmark. The agreement is for a period of 10 years and marks the company’s presence in this fast growing specialised dermatology segment.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Mid & small caps steal the show". Click here!

1 Responses to "Mid & small caps steal the show"

Snehal reddy

Apr 7, 2011

Pl send news letter

Like 
  
Equitymaster requests your view! Post a comment on "Mid & small caps steal the show". Click here!
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.